Two new flavonoids, named cambodianins D (1) and E (2), together with two known flavanes (2S)-7,4'-dihydroxy-6,8-dimethylflavane (3) and (2S)-7,3'-dihydroxy-4'-methoxy-8-methylflavane (4), were isolated from dragon's blood of Dracaena cambodiana. The new compounds were determined by HR-ESI-MS and spectroscopic techniques (UV, IR, 1D, and 2D NMR). Compounds 1-3 exhibited antimicrobial activities.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1080/10286020.2012.668534 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Loureirin B Accelerates Diabetic Wound Healing by Promoting TGFβ/Smad-Dependent Macrophage M2 Polarization: A Concerted Analytical Approach Through Single-Cell RNA Sequencing and Experimental Verification.
Phytother Res
November 2024
Department of Vascular Surgery, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Diabetic wound (DW) represent a significant clinical challenge and often fail to heal effectively. Loureirin B (LB), a flavonoid extracted from dragon's blood, has shown potential by influencing macrophage polarization and promoting wound healing. However, its mechanisms and efficacy in DW remain to be explored.
View Article and Find Full Text PDFEfficient Production of 4'-Hydroxydihydrochalcones Using Non-Conventional Yeast Strains.
Int J Mol Sci
October 2024
Department of Food Chemistry and Biocatalysis, Faculty of Biotechnology and Food Science, Wrocław University of Environmental and Life Sciences, 50-375 Wrocław, Poland.
The quest for novel therapeutic agents has rekindled interest in natural products, particularly those derived from biotransformation processes. Dihydrochalcones, a class of plant secondary metabolites, exhibit a range of pharmacological properties. Chalcone and dihydrochalcone compounds with the characteristic 4'-hydroxy substitution are present in 'dragon's blood' resin, known for its traditional medicinal uses and complex composition, making the isolation of these compounds challenging.
View Article and Find Full Text PDFMetabolomics and quantitative analysis to determine differences in the geographical origins and species of Chinese dragon's blood.
Front Plant Sci
September 2024
Hainan Provincial Key Laboratory of Resources Conservation and Development of Southern Medicine, Hainan Branch of the Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences and Peking Union Medical College, Haikou, China.
Objective: The aim of this study was to comprehensively analyze the differences in Chinese dragon's blood (CDB), specifically and , from different geographical origins.
Methods: Metabolomic analysis of CDB was performed by liquid chromatography-tandem mass spectrometry (LC-MS/MS). A reliable ultrahigh-performance liquid chromatography method with a photodiode array detector (UHPLC-PDA) was developed and applied for the quantitative analysis of 12 phenolic compounds in 51 batches of samples.
Longxuetongluo Capsule alleviate ischemia/reperfusion induced cardiomyocyte apoptosis through modulating oxidative stress and mitochondrial dysfunction.
Phytomedicine
November 2024
State Key Laboratory on Technologies for Chinese Medicine Pharmaceutical Process Control and Intelligent Manufacture, Jiangning Industrial City, Economic and Technological Development Zone, Lianyungang, Jiangsu 222001, China; Jiangsu Kanion Pharmaceutical Co Ltd, Jiangning Industrial City, Economic and Technological Development Zone, Lianyungang, Jiangsu 222001, China. Electronic address:
Article Synopsis
- Chinese dragon's blood is a red resin used in China to help treat heart and brain problems, especially after a stroke.
- Longxuetongluo Capsule (LTC) is made from this resin and is being studied to see how it can protect heart cells from damage after blood flow returns to the heart.
- In experiments with rats and heart cells, researchers found that LTC might help reduce damage to the heart by fixing some of the cell problems caused by low oxygen and sugar levels.
Release of natural extracts from PVA and PVA-CMC hydrogel wound dressings: a power law swelling/delivery.
Front Bioeng Biotechnol
August 2024
School of Mechanical and Manufacturing Engineering, Dublin City University, Dublin, Ireland.
Article Synopsis
- PVA hydrogels, while lacking in antimicrobial properties, can be enhanced by incorporating natural extracts like sage and dragon's blood, aiming to improve their effectiveness as wound dressings.
- Various analytical techniques (FTIR, DSC, tensile testing) were employed to assess the physical and mechanical properties of these modified hydrogels, along with testing their swelling and release characteristics.
- Results indicated that adding dragon's blood significantly changes the structure and enhances swelling capacity of the PVA gels, with a PVA-CMC formulation containing 15% dragon's blood offering optimal delivery characteristics and flexibility.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!